India's deeply rooted culture of self-medication — vidya ki vaidhyam, the belief that a little learning substitutes for a doctor — now drives nearly half of all antibiotic use without prescriptions, according to WHO and ICMR data, fuelling a drug-resistance crisis that the Lancet estimates already contributes to over 1 million global deaths annually.
Here is the scene that plays out ten thousand times every hour across India: a man walks into a pharmacy, describes a burning throat and a mild fever, and walks out three minutes later with a five-day course of azithromycin — no prescription, no diagnosis, no follow-up. He will take three of the five days' worth, feel better, and save the rest for the next time. That next time, the same pill may not work. And neither he nor the pharmacist will know why.
This is vidya ki vaidhyam in its most modern, most lethal avatar — the quiet confidence that a little knowledge, a previous experience, a forwarded WhatsApp message is medicine enough. The phrase, rooted in the Telugu tradition of trusting one's own learning as remedy, has always carried a gentle irony. In 2026, the irony has turned clinical.
The Numbers Behind the Counter
India is the world's largest consumer of antibiotics. According to the Indian Council of Medical Research's National Antibiotic Consumption Network (NAC-Net), antibiotic use in India grew by approximately 65% between 2000 and 2019, far outpacing population growth. The IHG Health Organization's 2024 report on antimicrobial resistance placed India among the nations where non-prescription antibiotic use exceeds 50% of total consumption — a figure that public-health researchers at the Lancet Infectious Diseases journal described as structurally embedded rather than incidental.
The market tells the same story from the supply side. India's over-the-counter pharmaceutical market, which includes self-medicated antibiotics, analgesics, cough syrups and antacids, is valued at approximately ₹89,000 crore, according to estimates from the Indian Pharmaceutical Alliance and industry trackers cited by the Economic Times. That is not a fringe habit; it is the economy of an entire parallel healthcare system operating without doctors.
Why the Pharmacy Counter Became the Clinic
The instinct is not irrational. India has roughly 0.7 physicians per 1,000 people, according to WHO's Global Health Workforce Statistics — below the organisation's own benchmark of 1 per 1,000. In rural Bihar, Madhya Pradesh and eastern Uttar Pradesh, the ratio drops further. A government primary health centre may be twenty kilometres away and open unpredictably. A pharmacy, by contrast, is almost always nearby, always open, and asks no questions.
Add to this the cost arithmetic. A consultation at a private clinic costs ₹300 to ₹800 in a Tier-2 city — before diagnostics, before the prescription itself. A direct pharmacy purchase of the same antibiotic strip costs ₹40 to ₹120. For a daily-wage earner, the calculus is not laziness; it is survival maths. The tragedy is that survival maths, repeated across a billion people, produces a collective catastrophe.
India Herald's read of what is really driving this crisis goes beyond the pharmacy counter. It is the absence of an affordable, accessible primary-care layer between the home and the hospital — a missing rung on the healthcare ladder that forces hundreds of millions of Indians to be their own doctors, armed with nothing but memory, Google and goodwill.
The Resistance Tax Nobody Sees
The consequence is not a hypothetical. Antimicrobial resistance — bacteria evolving to survive drugs — is already responsible for an estimated 1.27 million deaths globally per year, according to the landmark Lancet study published in 2022 and updated in subsequent analyses. India's share is disproportionately large: ICMR's annual AMR surveillance reports have documented rising resistance rates to commonly self-prescribed antibiotics like azithromycin, ciprofloxacin and amoxicillin, with resistance exceeding 70% for certain gram-negative infections in tertiary hospitals.
That 70% figure deserves a pause. It means that for some of India's most common infections, the first-line antibiotics that pharmacists dispense over the counter — the same pills the man with the sore throat reached for — simply do not work anymore in a significant majority of serious cases. The drugs are not failing because they are defective. They are failing because we used them casually, incompletely, and without guidance, and the bacteria took notes.
What makes this a peculiarly Indian paradox is that the country is simultaneously the world's largest manufacturer of generic antibiotics AND one of the largest incubators of resistance to those very antibiotics. India exports the cure and breeds the futility, often in the same postcode.
The Law That Exists on Paper
India's Drugs and Cosmetics Act requires Schedule H and Schedule H1 drugs — which include most antibiotics — to be sold only against a valid prescription. The rules exist. Enforcement, as the Central Drugs Standard Control Organisation (CDSCO) itself has periodically acknowledged, does not. State drug inspectors are chronically understaffed. The Drugs Controller General of India's own workforce data, reported by the Hindu, reveals that many states operate with fewer than half their sanctioned inspector posts filled. A pharmacist who sells azithromycin without a prescription faces, in practice, no consequence — and the customer expects exactly this frictionless access.
The regulatory gap is not accidental. It is politically convenient. No elected government wants to make medicine harder to access for voters who already struggle with healthcare costs. The result is a tacit national bargain: we will pretend the prescription rules exist, you will pretend to follow them, and the bacteria will be the only honest actors in the room.
What Comes Next — And What to Watch
ICMR's push for antibiotic stewardship programmes in hospitals has shown measurable results in institutional settings, reducing inappropriate prescriptions by 20-30% in pilot hospitals, according to ICMR's own programme evaluations. But hospital stewardship does not touch the vast ocean of community self-medication. The real frontier is the pharmacy counter itself — and here, the signals are mixed.
India's draft National Pharmacy Commission Bill, discussed in policy circles and reported by outlets including the Indian Express, proposes stricter digital tracking of prescription-drug sales. If implemented — and the if is seismic — it would require pharmacies to log prescriptions electronically before dispensing Schedule H drugs, creating the first real enforcement layer. But implementation requires state cooperation, digital infrastructure at over 900,000 retail pharmacies, and the political will to make medicine access marginally less convenient in the short term to save lives in the long term.
The more hopeful signal is telemedicine. Post-pandemic platforms like eSanjeevani, which logged over 100 million consultations by 2024 according to the Ministry of Health and Family Welfare, offer the missing rung — a ₹0-cost, phone-based consultation that can generate a legitimate prescription in minutes. If telemedicine can become the default first step before the pharmacy counter rather than an alternative to it, vidya ki vaidhyam may finally meet an accessible, affordable vaidhya.
Until then, the man at the pharmacy counter remains India's most dangerous doctor — not because he is ignorant, but because the system has given him no better option, and the bacteria have given him no second chances.
Reported and written with AI assistance under India Herald's editorial standards; a human editor governs publication.
This report is journalistic, not medical advice; consult a qualified professional for any health concern.
More from India Herald
Key Takeaways
- Over 50% of India's antibiotic consumption happens without a prescription, according to WHO and ICMR data — making self-medication a structural public-health crisis, not an individual failing.
- ICMR surveillance reports show resistance exceeding 70% for certain first-line antibiotics in serious infections — the drugs millions self-prescribe are already failing in hospitals.
- India's OTC pharma market is valued at roughly ₹89,000 crore, representing a parallel healthcare system operating entirely without physician oversight.
- The physician shortage (0.7 per 1,000 vs. WHO's 1-per-1,000 benchmark) and consultation costs structurally push patients toward pharmacy-counter self-diagnosis.
- Telemedicine platforms like eSanjeevani (100M+ consultations by 2024) offer the most realistic path to inserting a doctor between the patient and the pharmacy counter.
By the Numbers
- India's antibiotic consumption grew ~65% between 2000 and 2019, far outpacing population growth — ICMR NAC-Net
- Antimicrobial resistance contributes to an estimated 1.27 million deaths globally per year — Lancet 2022
- India's OTC pharmaceutical market valued at approximately ₹89,000 crore — Indian Pharmaceutical Alliance estimates via Economic Times
- India averages 0.7 physicians per 1,000 population against WHO's recommended 1 per 1,000
- Resistance to commonly self-prescribed antibiotics like azithromycin exceeds 70% for certain gram-negative infections in Indian tertiary hospitals — ICMR AMR surveillance
- eSanjeevani telemedicine platform crossed 100 million consultations by 2024 — Ministry of Health and Family Welfare
click and follow Indiaherald WhatsApp channel